Aldeyra Therapeutics, Inc.
(NASDAQ : ALDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.25%104.901.1%$1268.27m
GILDGilead Sciences, Inc.
-0.06%72.780.9%$641.23m
AMGNAmgen Inc.
0.18%170.271.1%$478.82m
REGNRegeneron Pharmaceuticals, Inc.
0.69%390.202.7%$361.56m
BIIBBiogen Inc.
-0.38%308.611.2%$348.46m
ALXNAlexion Pharmaceuticals, Inc.
0.60%108.241.9%$268.23m
VRTXVertex Pharmaceuticals Incorporated
-0.29%146.621.9%$232.06m
ALNYAlnylam Pharmaceuticals, Inc
1.09%133.7710.0%$195.26m
INCYIncyte Corporation
-0.29%98.712.5%$178.72m
NKTRNektar Therapeutics
-1.14%49.186.1%$174.56m
ILMNIllumina, Inc.
-0.12%215.103.5%$154.34m
JUNOJuno Therapeutics, Inc.
2.01%61.5413.5%$140.39m
AAgilent Technologies, Inc.
0.48%69.021.5%$132.29m
SRPTSarepta Therapeutics, Inc.
0.34%56.4116.8%$116.02m
BLUEBluebird Bio, Inc.
0.72%168.4017.2%$115.25m

Company Profile

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.